Genetic analysis of 53 lymph node-negative breast carcinomas by CGH and relation to clinical, pathological, morphometric, and DNA cytometric prognostic factors

Journal of Pathology

Volumn 186, Issue 4, 1998, Pages 356-362

  Hermsen, Mario A J A ^a   Baak, Jan P A ^a   Meijer, Gerrit A ^a   Weiss, Janneke M ^a   Walboomers, Jan W W ^a   Snijders, Peter J F ^a   Van Diest, Paul J ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Breast cancer; Chromosomal aberrations; Comparative genomic hybridization; Prognosis; Quantitative pathology

Indexed keywords

ADULT; AGED; ARTICLE; BREAST CARCINOMA; CANCER CYTODIAGNOSIS; CANCER STAGING; CHROMOSOME 1; CHROMOSOME 19P; CHROMOSOME 22Q; CHROMOSOME 3Q; CHROMOSOME 4; CHROMOSOME 5Q; CHROMOSOME 8; CHROMOSOME ABERRATION; CHROMOSOME LOSS; CHROMOSOME XQ; CYTOMETRY; DIAGNOSTIC VALUE; FEMALE; GENETIC ANALYSIS; HUMAN; HUMAN TISSUE; LYMPH NODE BIOPSY; PRIORITY JOURNAL; PROGNOSIS; QUANTITATIVE ASSAY;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; CHROMOSOME ABERRATIONS; DNA, NEOPLASM; FEMALE; FLOW CYTOMETRY; HUMANS; LYMPHATIC METASTASIS; MIDDLE AGED; NUCLEIC ACID HYBRIDIZATION; PLOIDIES; PROGNOSIS;

EID: 0032415839     PISSN: 00223417     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9896(199812)186:4<356::AID-PATH196>3.0.CO;2-Z     Document Type: Article

References (32)

1. Baak JPA, Chin D, Diest PJ van, Matze-Cok P, Bacus SS. Comparative long term prognostic value of quantitative HER-2/neu protein expression, DNA ploidy, morphometric and clinical features in paraffin-embedded invasive breast cancer. Lab Invest 1991; 64: 215-222.
2. Diest PJ van, Baak JPA. The morphometric Multivariate Prognostic Index (MPI) is the strongest prognosticator in premenopausal lymph node negative and lymph node positive breast cancer patients. Hum Pathol 1991; 22: 326-330.
3. Bièche I, Lidereau R. Genetic alterations in breast cancer. Genes Chrom Cancer 1995; 14: 227-251.
4. Kallioniemi A, Kallioniemi OP, Sudar D, et al. Comparative genomic hybridization for molecular cytogenetic analysis of solid tumours. Science 1992; 258: 818-821.
5. Manoir S du, Speicher MR, Joos S, et al. Detection of complete and partial chromosome gains and losses by comparative genomic in situ hybridization. Hum Genet 1993; 90: 590-610.
6. Speicher MR, Du Manoir S, Schröck E, et al. Molecular cytogenetic analysis of formalin-fixed paraffin-embedded solid tumours by comparative genomic hybridization after universal DNA-amplification. Hum Mol Genet 1993; 2: 1907-1914.
7. Isola J, DeVries S, Chu L, Ghazvini S, Waldman F. Analysis of changes in DNA sequence copy number by comparative genomic hybridization in archival paraffin-embedded tumour samples. Am J Pathol 1994; 145: 1301-1308.
8. Hermsen MAJA, Joenje H, Arwert F, et al. Assessment of chromosomal gains and losses in oral squamous cell carcinoma by comparative genomic hybridisation. Eur J Cancer 1997; 33: 414-418.
9. Fleege JC, Van Diest PJ, Baak JPA. Refinement and multi-observer evaluation of systematic random sampling to improve reproducibility in interactive nuclear morphometry. Anal Quant Cytol Histol 1993; 15: 281-289.
10. Isola JJ, Kallioniemi O-P, Chu LW, et al. Genetic aberrations detected by comparative genomic hybridization predict outcome in node-negative breast cancer. Am J Pathol 1995; 147: 905-911.
11. Pandis N, Idvall I, Bardi G, et al. Correlation between karyotypic pattern and clinicopathologic features in 125 breast cancer cases. Int J Cancer 1996; 66: 191-196.
12. Ried T, Just KE, Holtgreve-Grez H, et al. Comparative genomic hybridization of formalin-fixed, paraffin-embedded breast tumours reveals different patterns of chromosomal gains and losses in fibroadenomas and diploid and aneuploid carcinomas. Cancer Res 1995; 55: 5415-5423.
13. Muleris M, Almeida A, Gerbeult-Seureau M, Malfoy B, Dutrillaux B. Detection of DNA amplification in 17 primary breast carcinomas with homogeneously staining regions by a modified comparative genomic hybridization technique. Genes Chrom Cancer 1994; 10: 160-170.
14. Pandis N, Jin Y, Gorunova L, et al. Chromosome analysis of 97 primary breast carcinomas: identification of eight karyotypic subgroups. Genes Chrom Cancer 1995; 12: 173-185.
15. Zafrani B, Gerbeult-Seureau M, Mosseri V, Dutrillaux B. Cytogenetic study of breast cancer: clinico-pathologic significance of homogeneously staining regions in 84 patients. Hum Pathol 1992; 23: 542-547.
16. Thompson F, Emerson J, Dalton W, et al. Clonal chromosome abnormalities in human breast carcinomas I. Twenty-eight cases with primary disease. Genes Chrom Cancer 1993; 7: 185-193.
17. Gudmundsson J, Barkardottir RB, Eiriksdottir G, et al. Loss of heterozygosity at chromosome 11 in breast cancer: association of prognostic factors with genetic alterations. Br J Cancer 1995; 71: 696-701.
18. Carter SL, Negrini M, Baffa R, et al. Loss of heterozygosity at 11q22-q23 in breast cancer. Cancer Res 1994; 54: 6270-6274.
19. Oka H, Shiozaki H, Kobayashi K, et al. Expression of E-cadherin cell adhesion molecules in human breast cancer tissues and its relationship to metastasis. Cancer Res 1993; 53: 1696-1701.
20. Kuukasjärvi T, Karhu R, Tanner M, Kallioniemi OP, Isola J. Analysis of the genetic evolution of breast cancer from primary tumours to distant metastases by comparative genomic hybridization. European Conference on Comparative Genomic Hybridization, Semmering, Austria, 29 February-2 March 1996, Abstract.
21. Mokotura T, Bloom T, Goo Kim H, et al. A novel cyclin encoded by a bcl1-linked candidate oncogene. Nature 1991; 350: 512-515.
22. Schuuring E, Verhoeven E, Van Tinteren H, et al. Amplification of genes within the chromosome 11q13 region is indicative of poor prognosis in patients with operable breast cancer. Cancer Res 1992; 52: 5229-5234.
23. Champème MH, Bièche I, Lizard S, Lidereau R. 11q13 amplificaton is involved in local recurrence of human-primary breast cancer. Genes Chrom Cancer 1995; 12: 128-133.
24. Borg A, Baldetorp B, Ferno M, Kilander D, Olsson H, Sigurdsson H. ERBB2 amplification in breast cancer with a high rate of proliferation. Oncogene 1991; 6: 137-143.
25. Easton DF, Bishop DT, Ford D, Crockford GP, the Breast Cancer Consortium. Genetic linkage analysis in familial breast and ovarian cancer: results from 214 families. Am J Hum Genet 1993; 52: 678-701.
26. Tanner MM, Tirkkonen M, Kallioniemi A, et al. Increased copy number at 20q13 in breast cancer: defining the critical region and exclusion of candidate genes. Cancer Res 1994; 54: 4257-4260.
27. Kinzler KW, Vogelstein B. Gatekeepers and caretakers. Nature 1997; 386: 761-763.
28. Fujiwara Y, Ohata H, Emi M, et al. A 3 Mb physical map of the chromosome region 8p21.3-p22, including a 600kb region commonly deleted in human hepatocellular carcinoma, colorectal cancer, and non-small cell lung cancer. Genes Chrom Cancer 1994; 10: 7-14.
29. Lindblom A, Skoog L, Rotstein S, Werelius B, Larsson C, Nordenskjold M. Loss of heterozygosity in familial breast carcinomas. Cancer Res 1993; 53: 4356-4361.
30. Kerangueven F, Adelaide J, Dib A, et al. Allelic loss at chromosome 8p in breast cancer. Oncol Rep 1994; 1: 393-395.
31. Yaremko ML, Recant WM, Westbrook CA. Loss of heterozygosity from the short arm of chromosome 8 is an early event in breast cancers. Genes Chrom Cancer 1995; 13: 186-191.
32. Kallioniemi OP, Kallioniemi A, Piper J, et al. Optimizing comparative genomic hybridization for analysis of DNA sequence copy number changes in solid tumours. Genes Chrom Cancer 1994; 10: 231-243.